Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) belongs to Healthcare sector. Its weekly performance is 17.86%. On last trading day company shares ended up $9.90. Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) distance from 50-day simple moving average (SMA50) is 47.62%. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), presented at the Jefferies 2015 Global Healthcare Conference in New York City. Seth Lederman, M.D., Tonix’s chairman and chief executive officer, delivered a corporate overview on Thursday, June 4, 2015 at 8:00 am ET.
PTC Therapeutics, Inc. (NASDAQ:PTCT) shares moved down -5.09% in last trading session and ended the day at $47.69. PTCT return on assets is -43.10%. PTC Therapeutics, Inc. (NASDAQ:PTCT) quarterly performance is -38.49%. PTC Therapeutics, Inc. (NASDAQ:PTCT) announced the appointment of Glenn D. Steele Jr., M.D., Ph.D. to the company’s Board of Directors. Dr. Steele served as President and Chief Executive Officer of Geisinger Health from March 2001 until May 2015 and is now Chairman of xG Health Solutions, a Geisinger spinoff.
On 16 June, The J. M. Smucker Company (NYSE:SJM) shares advanced 1.23% and was closed at $112.35. SJM EPS growth in last 5 year was -4.30%. The J. M. Smucker Company (NYSE:SJM) year to date (YTD) performance is 12.51%. On 4 June, The J. M. Smucker Company (NYSE:SJM) said it lost $90.3 million, or 82 cents per share, in the fiscal fourth quarter. Excluding costs related to the Big Heart purchase, debt retirement costs, and other one-time items, Smucker said it earned 98 cents per share over the three months that ended on April 30. Its revenue totaled $1.45 billion.
JD.com, Inc. (NASDAQ:JD) ended the last trading day at $36.50. Company weekly volatility is calculated as 2.65% and price to cash ratio as 10.77. JD.com, Inc. (NASDAQ:JD) showed a weekly performance of 0.19%. JD.com Inc., (NASDAQ:JD) the Chinese e-commerce company that competes with Alibaba Group Holding Ltd., is starting a Russian-language website this week to fuel growth beyond its home market.
Blucora, Inc. (NASDAQ:BCOR) shares moved down -0.18% in last trading session and ended the day at $16.37. BCOR Gross Margin is 47.50% and its return on assets is -4.30%. Blucora, Inc. (NASDAQ:BCOR) quarterly performance is 14.00%. Blucora (NASDAQ:BCOR) was upgraded by Zacks from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Wednesday. The firm currently has a $18.00 target price on the stock. Zacks‘s price objective would suggest a potential upside of 12.50% from the company’s current price.